TRDA
Entrada Therapeutics Inc
6.20$
-4.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 79.0% | 78.8% | 81.1% | 84.1% | 83.9% | 83.6% | 82.9% | 82.3% | 81.9% | 81.2% | 79.5% | 77.9% | |
| 10.7% | 14.4% | 13.4% | 31.8% | 14.1% | 19.2% | 13.9% | 16.2% | 22.6% | 24.0% | 22.8% | 33.2% | |
| 72.9% | 75.0% | 64.1% | 80.7% | 81.0% | 79.8% | 78.6% | 78.9% | 79.2% | 78.4% | 76.0% | 74.6% | |
| 1.0% | 1.3% | 15.2% | 1.3% | 0.5% | 0.7% | 0.4% | 0.3% | 0.8% | 0.3% | 0.7% | 0.3% | |
| -1.0% | 0.0% | 0.0% | – | -0.7% | – | – | – | – | – | – | – | |
| 49.1% | 48.3% | 47.3% | 26.1% | 23.8% | 18.6% | 14.2% | 15.4% | 17.5% | 18.9% | 19.3% | 21.9% | |
| 34.1% | 33.8% | 34.0% | 14.7% | 12.7% | 7.5% | 3.8% | 4.4% | 5.8% | 6.5% | 5.7% | 7.2% | |
| 1.4% | 1.7% | 1.6% | 1.5% | 1.4% | 1.4% | 1.3% | 1.2% | 1.1% | 1.1% | 1.3% | 1.5% | |
| 0.2% | 0.7% | 0.5% | 0.3% | 0.2% | 0.8% | 0.4% | 0.4% | 0.8% | 0.6% | 0.9% | 1.3% | |
| 50.9% | 51.7% | 52.7% | 73.9% | 76.2% | 81.4% | 85.8% | 84.6% | 82.5% | 81.1% | 80.7% | 78.1% | |
| -38.2% | -41.6% | -33.6% | -20.0% | -23.5% | -24.6% | -30.2% | -42.3% | -56.7% | -72.4% | -93.2% | -119.0% | |
| 7.2% | 7.1% | 6.8% | 6.1% | 7.3% | 8.2% | 8.4% | 9.2% | 10.0% | 11.0% | 12.5% | 14.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.